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Mutations in DOCK7 in Individuals
with Epileptic Encephalopathy and Cortical Blindness
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Epileptic encephalopathies are increasingly thought to be of genetic origin, although the exact etiology remains uncertain in many
cases. We describe here three girls from two nonconsanguineous families affected by a clinical entity characterized by dysmorphic fea-
tures, early-onset intractable epilepsy, intellectual disability, and cortical blindness. In individuals from each family, brain imaging also
showed specific changes, including an abnormally marked pontobulbar sulcus and abnormal signals (T2 hyperintensities) and atrophy
in the occipital lobe. Exome sequencing performed in the first family did not reveal any gene with rare homozygous variants shared by
both affected siblings. It did, however, show one gene,DOCK7, with two rare heterozygous variants (c.2510delA [p.Asp837Alafs*48] and
c.3709C>T [p.Arg1237*]) found in both affected sisters. Exome sequencing performed in the proband of the second family also showed
the presence of two rare heterozygous variants (c.983C>G [p.Ser328*] and c.6232G>T [p.Glu2078*]) in DOCK7. Sanger sequencing
confirmed that all three individuals are compound heterozygotes for these truncating mutations in DOCK7. These mutations have
not been observed in public SNP databases and are predicted to abolish domains critical for DOCK7 function. DOCK7 codes for a Rac
guanine nucleotide exchange factor that has been implicated in the genesis and polarization of newborn pyramidal neurons and in
the morphological differentiation of GABAergic interneurons in the developing cortex. All together, these observations suggest that
loss of DOCK7 function causes a syndromic form of epileptic encephalopathy by affecting multiple neuronal processes.Epileptic encephalopathies (EEs) are a heterogeneous
group of severe disorders that are characterized by seizures
and abundant epileptiform activity and contribute to
cognitive and behavioral impairment.1 Genetics is
believed to play a major role in these conditions. Although
current observations suggest the involvement of hundreds
of genes in EE, their identity has only been elucidated in a
small proportion of cases.2 Moreover, genes whose muta-
tions are known to cause EE are typically associated with
variable and overlapping phenotypes, complicating the
establishment of etiological diagnoses in clinical settings.
Although EE-causing mutations in several genes have
been shown to affect metabolic pathways or ion-channel
function, other genes found to be mutated in EE are specif-
ically associated with the regulation of developmental pro-
cesses, including the proliferation of neuronal progenitors,
the differentiation andmigration of neurons, and the elab-
oration of neuronal circuits. Very little is known about the
identity and mechanisms of action of these EE-associated
developmental genes. We describe here two unrelated
families affected by a specific condition characterized by
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The Amstructural brain abnormalities. Using exome sequencing,
we identified mutations in DOCK7, a regulator of neuronal
development, in the two families, providing insight into
the pathophysiology of EE.
This study was approved by the ethics committees of the
participating institutions, and informed consent was
obtained from each participant or legal guardian. The first
family (family A), consisting of two affected female siblings
(A-1 and A-2) born to nonconsanguineous healthy French
Canadian parents, was recruited at Sainte-Justine Hospital
(Montreal). Individuals A-1 and A-2 are currently 7 and 5
years old, respectively. They were born at term after
unremarkable pregnancy and delivery. Their neonatal
course was uneventful, but in individual A-1, the discovery
of a heart murmur led to a diagnosis of aortic supravalvular
stenosis and bicuspid valve, for which the child was
operated on at 4 months of age. Echocardiography was
normal in individual A-2.
Both sisters presented with tonic seizures between 2 and
4 months of age. At 1 year of age, individual A-1 displayed
infantile spasms, which disappeared with the administra-
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Figure 1. Pictures of Individuals with Mutations in DOCK7
Frontal and profile photos of the faces of affected individuals from
families A (A-1 and A-2) and B (B-1). These individuals display
similar dysmorphic features, including a low anterior hairline,
periorbital fullness, telecanthus, a broad nasal tip, and anteverted
nares.A-2 started to showmyoclonus, which occurred asmany as
50 times a day. Over the following months, individual A-2
started to show different types of seizures, including myoc-
lonus, partial complex seizures with rotation of the head,
drop attacks, and tonic seizures. Control was poor in
both sisters despite the administration of multiple antiep-
ileptic drugs in various combinations and several trials
with the ketogenic diet. Electroencephalography (EEG)
performed at 11 months of age in individual A-1 showed
a pattern consistent with hypsarrhythmia, whereas EEG
performed at 2 months of age in individual A-2 showed
epileptic activity in the left posterior quadrant and in the
right temporoparietal region. Subsequent EEG studies
showed multifocal epileptic activity in both sisters.
Parents noticed a lack of attentiveness to visual stimuli
in their children during the first few months of life.
Ophthalmological examinations showed normal eye
movements, pupillary reaction, and fundus in both sisters,
consistent with a diagnosis of cortical blindness. Progres-892 The American Journal of Human Genetics 94, 891–897, June 5, 2sive improvement over the following years was noted.
Currently, individual A-1 displays grossly normal visual
pursuit, although she has more difficulty following objects
in the upper visual fields, whereas individual A-2 can now
follow a moving object, but she does not see well enough
to play with toys.
Individual A-1 started to walk at 20 months of age, but
her gross motor skills deteriorated over the last few years.
She can now get up by herself but cannot walk without
help. She cannot eat by herself. She does not point or use
her hands to communicate. She can hit objects against
each other. She does not speak, but she can understand a
few simple commands. She can smile, but not in a social
context. She displays limited visual contact. Overall, her
nonverbal interactions are suggestive of autism. Individual
A-2 began walking at 28 months of age. Currently, she can
run but cannot jump in place. She can eat with a spoon
and has a pincer grasp but cannot point to objects. She
can say about 30 words and associate two words. She can
designate body parts on demand and understand simple
commands.
The occipitofrontal circumference (OFC) of individual
A-1 was 45 cm (tenth percentile) at 19 months of age,
whereas that of individual A-2 was 42.2 cm (tenth percen-
tile) at 8 months of age. Both sisters showed similar facial
features, including a low anterior hairline, some periorbital
fullness, telecanthus, and a broad nasal tip with anteverted
nares (Figures 1A and 1B). Neurological examination was
unremarkable in both of them.
Karyotyping was normal in both siblings. In addition,
array genomic hybridization (105K-feature whole-genome
microarray, Signature Genomic Laboratories) did not show
any abnormality in individual A-2. Mutation analysis of
MECP2 (MIM 300005) and CDKL5 (MIM 300203) in
individual A-1 and a methylation study of the region
associated with Angelman syndrome (MIM 105830) in in-
dividual A-2 were unremarkable. A metabolic work-up,
including plasma amino acid and urine organic acid chro-
matography, was normal in both sisters. Brain MRI per-
formed at 25 months of age in individual A-1 showed an
abnormally marked pontobulbar sulcus associated with
mild pontine hypoplasia, a thin and short corpus
callosum, and abnormal signals (T2 hyperintensities) and
atrophy in the white and gray matter of the occipital
region (Figures 2A, 2C, 2D, 2F, 2G, 2I, 2K, and 2M). Brain
MRI performed at 8 months of age in individual A-2
showed mild hypoplasia of the corpus callosum according
to the report of the radiologist who interpreted the images.
These images were not available for review. Brain spectros-
copy revealed normal creatine, N-acetylaspartic acid, and
choline levels in both sisters.
The exomes of these affected individuals (A-1 and A-2)
were captured from blood genomic DNA with the use of
Agilent SureSelect Human All Exon Kit V4 and were
sequenced (2 3 100 bp, three exomes per lane) with
the Illumina HiSeq2000 at the McGill University and
Genome Quebec Innovation Center (Montreal). Sequence014
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Figure 2. Brain MRI of Individuals with Mutations in DOCK7
MRI was performed at 2 years of age in individuals A-1 (A, D, and G) and B-1 (B, E, H, J, and L) and a control individual who was also
matched for sex (C, F, I, K, andM) by means of the following modalities: axial T2 (A, J, and K), axial T1 (B, C, L, andM), sagittal T1 (D–F),
coronal T2 (G), and coronal FLAIR (H and I).
(A–F) Abnormallymarked pontobulbar sulcus (white arrows) andmild pontine hypoplasia in individuals A-1 (A andD) and B-1 (B and E).
See the control individual in (C) and (F) for comparison.
(G–K) Hypersignal and atrophy in the occipital cortex (white arrows), including in the regions lining the calcarine sulcus, in individual
A-1 (G). See the control individual in (I) and (K) for comparison.
(L and M) Dedifferentiation of the occipital cortex and white matter with a sequellae aspect in individual B-1 (L). See the control indi-
vidual in (M) for comparison.processing, alignment (with the Burrows-Wheeler
Aligner), and variant calling were done with the Broad
Institute Genome Analysis Toolkit (GATK v.4) and anno-
tated with ANNOVAR.3 The average exome coverage of
the target bases was 1213 (A-1) and 1413 (A-2), and 99%
of the target region was covered by at least ten reads. In
view of the likely autosomal-recessive mode of inheritance
in this family, we only considered well-covered variants
(R103) that were shared by both affected sisters. We
next filtered out (1) synonymous or intronic variants other
than those affecting the consensus splice sites, (2) variants
seen in more than 1% of an in-house exome data set (n ¼
600) from unrelated projects, and (3) variants with aminor
allele frequency greater than 0.5% in either 1000 Genomes
or the NHLBI Exome Sequencing Project Exome Variant
Server (EVS). This filtering strategy resulted in a total of
154 variants shared by both sisters, and none of them
affected genes associated with intellectual disability (ID)
or epilepsy. None of these variants were homozygous.
Only one gene, DOCK7, showed multiple heterozygous
variants (c.3709C>T [p.Arg1237*] [RefSeq accession
number NM_001271999.1, chr1:62995020G>A] andThe Amc.2510delA [p.Asp837Alafs*48] [chr1:63021582T>delT];
UCSC Genome Browser hg19 assembly) shared by both
sisters. Sanger sequencing showed that both sisters are
compound heterozygotes for these mutations (Figure 3A).
The second family (B) was referred to the Department of
Genetics of Hoˆpital Necker – Enfants Malades (Paris)
because of congenital blindness in the first of three daugh-
ters born to nonconsanguineous healthy French parents.
The affected individual (B-1), who is currently 10 years
old, was born at term after an unremarkable delivery. The
initial course was uneventful until the parents noticed
the absence of visual contact in the infant. Ophthalmo-
logic examination performed at the age of 6 months
showed the absence of ocular reaction to visual threat,
normal pupillary reflex, and normal aspect of the fundus.
Evoked visual potentials were unremarkable, but electroret-
inographic (ERG) traces were ambiguous. Ophthalmolog-
ical examinations repeated at 2 and 9 years of age showed
unchanged retinal aspect and normal ERG traces, leading
to the diagnosis of cortical blindness. Currently, at age 10,
she shows wandering eye movements and a complete
absence of reaction to visual threat and light stimulation.erican Journal of Human Genetics 94, 891–897, June 5, 2014 893
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Figure 3. Truncating Mutations in DOCK7 in Individuals with EE and Cortical Blindness
(A) Pedigrees of the two families affected by DOCK7 mutations and chromatograms of these mutations.
(B) A schematic of DOCK7 (2,129 amino acids) shows its DOCK homology domains, DHR-1 (amino acids 516–727) and DHR-2 (amino
acids 1,668–2,110), as well as the TACC3-binding region (T-b) and the relative amino acid positions of the identified alterations.
Nucleotide and amino acid positions are based on RefSeq NM _001271999.1 and NP_001258928.1, respectively. Locations of the
DHR-1 and DHR-2 domains are based on DOCK7 UniProt prediction (accession number Q96NS7, isoform 2), and the positions of
the T-b boundaries are based on Yang et al.4Seizures were first noticed at 6 months of age and were
initially characterized by eye revulsion and rhythmic arm
and body movements. Initial EEG recordings performed
at the age of 7.5 months showed left occipital epileptic
activity. Subsequently, she showed short absences with
immobility, moderate body sagging, and unreactiveness
to external stimuli. EEG recordings at 2–3 years of age
showed multifocal epileptic activity associated with occa-
sional electroclinical spasms. Currently, despite the admin-
istration of various antiepileptic drugs alone or in com-
bination, she experiences repeated tonic-clonic seizures.
The psychomotor development of individual B-1 was
initially unremarkable except for the presence of moderate
hypotonia. She started to walk at 22months of age, but she
did not acquire any new skills thereafter. She can walk
without help in known environments. Her speech skills894 The American Journal of Human Genetics 94, 891–897, June 5, 2are limited to repeating the last three words of sentences
that she hears. She understands simple commands. She
can smile, but not in a social context. She uses her hands
to grasp objects, but not to point or communicate.
She can bring a spoon to her mouth, but she is unable to
eat by herself. She manifests hand, trunk, and head
(screwing and unscrewing movements) stereotypies.
Since the neonatal period, her weight and size have been
on þ2–3 SDs, contrasting with an OFC on 1 SD. She ex-
hibits dysmorphic facial features, including bitemporal
narrowness, a low anterior hairline, thick and duplicated
eyebrows, synophrisis, long eyelashes, enophthalmia, a
large and prominent nasal root, a bulbous nasal tip, a thick
and hammered helix, thick earlobes, a short philtrum, full
lips and an everted lower lip, and spaced incisors (Fig-
ures 1E and 1F). Currently, her neurological exam is014
unremarkable. Karyotyping at a resolution of 400 bands
was normal. In addition, array genomic hybridization
(Affimetrix Cytogenetics Whole-Genome 2.7M Array) did
not show any de novo abnormality in individual B-1.
Brain MRI performed at the age of 2 years showed an
abnormally marked pontobulbar sulcus, mild pontine
hypoplasia, and abnormal signals (T2 hyperintensities)
with atrophy in the occipital white and gray matter (Fig-
ures 2B, 2C, 2E, 2F, and 2H–2M).
The exome of proband B-1 was captured from blood
genomic DNA with the use of the SureSelect Human All
Exon Kit V3 (Agilent) and sequenced (2 3 75 bp) with
the Illumina HiSeq2000 system at the Genomic Core
Facility of Institut Imagine (Paris). Sequences were aligned
to the human genome reference sequence (UCSC Genome
Browser hg19 assembly), and SNPs were called on the basis
of allele calls and read depth with the use of the Consensus
Assessment of Sequence and Variation pipeline (v.1.8,
Illumina). Genetic-variation annotation was performed
by an in-house pipeline. The average exome coverage of
the target bases was 783, and 88% of the target region
was covered by at least 15 reads. Only the variants whose
positions were covered R103 were further considered.
The filtering strategy used for analyzing the exome of
individual B-1 was the same as that described above. On
the basis of our finding in family A, we also hypothesized
an autosomal-recessive mode of inheritance in family B
and focused our attention on homozygous and multiple
heterozygous variants. In total, nine variants (one
homozygous and eight heterozygous variants) in five
genes met these criteria, and none of them affected
genes known to be associated with ID or epilepsy (Table
S1, available online). Among these variants, we
identified two heterozygous truncating mutations in
DOCK7: c.983C>G (p.Ser328*) (chr1:63100496G>C) and
c.6232G>T (p.Glu2078*) (chr1:62923324C>A, RefSeq
NM_001271999.1, UCSC Genome Browser hg19 as-
sembly). Sanger sequencing showed that individual B-1 is
a compound heterozygote for these mutations and that
her two unaffected siblings do not carry any of them
(Figure 3A).
None of the fourDOCK7mutations identified in families
A and B have been previously reported in any public SNP
database (1000 Genomes, dbSNP, or the NHLBI EVS). We
also searched our in-house database of 1,500 similarly
sequenced exomes, including 200 exomes from French
Canadians, and we did not identify any of these four mu-
tations or any other truncating or splicing ones in DOCK7.
Moreover, inspection of DOCK7 for loss-of-function
(splicing, nonsense, and frameshift) variants in the NHLBI
EVS revealed only two heterozygous truncating variants, in
two different individuals, out of approximately 13,000
alleles from individuals with European American and
African American ancestry. These observations indicate
that DOCK7, despite its large size (2,129 amino acids),
does not accumulate loss-of-function-variants in the
general population, suggesting that its disruption mightThe Ambe detrimental in humans. We further used Sanger
sequencing to screen the coding exons and flanking
intronic regions of DOCK7 (Table S2) in 35 EE-affected
individuals with burst suppression (n ¼ 18/35); infantile
migrating partial seizures and no mutations in KCNT1
(MIM 608167), SNC1A (MIM 182389), PLBC1, TBC1D24
(MIM 613577), or SLC25A22 (MIM 609302) (n ¼ 11/35);
or Rett-like syndrome (MIM 312750) and no mutations
in MECP2 or CDKL5 (n ¼ 6/35). We identified polymor-
phisms, but no candidate single heterozygous or biallelic
mutations, in these individuals (Table S3).
DOCK7 is a member of the DOCK180-related protein
superfamily, which emerged as a distinct class of guanine
nucleotide exchange factors (GEFs) for Rac and/or Cdc42
GTPases.5 Like other DOCK180-related proteins, DOCK7
is characterized by the presence of a DHR1 domain, which
is predicted to bind phospholipids and thus facilitate
recruitment to the plasma membrane, and of a catalytic
DHR2 domain, which positively regulates Rac and Cdc42
by promoting the exchange of GDP for GTP.6,7 The muta-
tions identified in both families affect all the majorDOCK7
isoforms and are located in upstream exons, indicating
that they have the potential to induce nonsense-mediated
decay of the corresponding mRNAs.8 These mutations are
also predicted to abolish the conserved domains of
DOCK7 and are thus likely to cause a loss of its function
(Figure 3B).
The individuals described here show a similar pheno-
type, characterized by intractable seizures, ID, and cortical
blindness. At least two of them also share distinctive brain
MRI changes characterized by a strikingly marked ponto-
bulbar sulcus and abnormal MRI signals with atrophy in
the occipital lobe. Moreover, these individuals show
similar dysmorphic features, including a low anterior
hairline, periorbital fullness, telecanthus, a broad nasal
tip, and anteverted nares. The identification of multiple
rare and deleterious mutations in DOCK7 in unrelated
individuals with such a unique phenotype strongly sug-
gests that it is the causal gene.
DOCK7 is located in all major regions of the brain,
including the cortex and hippocampus, from early embry-
onic to postnatal stages and is present in lower amounts in
adulthood.4 Knockdown experiments performed in vitro
and in vivo showed that DOCK7 regulates neurogenesis
by promoting the differentiation of progenitors into
neurons.4 During the cell cycle, the nuclei of neuronal pro-
genitors migrate between the apical and basal aspects of
the ventricular zone. DOCK7 influences neuronal differen-
tiation by impeding basal-to-apical interkinetic nuclear
migration. This leads to extended residency of progenitors
at the basal aspect of the ventricular zone, resulting in
ectopic mitoses, which are more likely to generate neurons
than self-renewing progenitors. DOCK7 exerts its effect by
directly antagonizing the microtubule-growth-promoting
function of the centrosome-associated protein TACC3 in
a GEF-independent fashion. DOCK7 interaction with
TACC3 is mediated by a protein region that is locatederican Journal of Human Genetics 94, 891–897, June 5, 2014 895
between the DHR1 and DHR2 domains. Importantly, other
DOCK-180 family members do not compensate for this
function of DOCK7, given that knockdown of DOCK7
alone is sufficient to cause defects in neurogenesis.
DOCK7 is also required for the regulation of neuronal
polarity. It promotes the development of nascent axons
by activating Rac1, which leads to the phosphorylation
and inactivation of the microtubule-destabilizing protein
Op18.6 In contrast to its role in neurogenesis, this function
of DOCK7 is thus mediated by its GEF activity. Recruit-
ment of DOCK7 at the plasma membrane via the binding
of DHR1 to PtdIns(3,4,5)P3 also appears to be important for
its function in axonal development.6 Interestingly, in vivo
expression of DOCK7 in the developing cortex results
in the accumulation of multipolar neurons that show
impaired migration.4 All together, these observations indi-
cate that DOCK7 is an important regulator of microtubule
assembly both in the context of neurogenesis and in the
establishment of neuronal polarity.
In addition to playing a role in prospective pyramidal
neurons, DOCK7 also controls the development of
GABAergic interneurons. DOCK7 is present in chandelier
cells, a subtype of cortical interneurons that have powerful
control over the output of pyramidal neurons.9 Knock-
down of mouse ortholog Dock7 causes a reduction of the
number and size of synaptic boutons formed by these cells.
DOCK7 controls the development of chandelier cells by
physically interacting with the receptor tyrosine kinase
ERBB4 and enhancing its activation and does so indepen-
dently of its GEF activity.9 Interestingly, ERBB4 (MIM
600543) haploinsufficiency has been described in individ-
uals with EE or moderate ID.10,11 Collectively, these obser-
vations indicate that DOCK7 exerts distinct roles in
different cell types during brain development by interact-
ing with a variety of protein complexes. Two spontaneous
truncating alleles of Dock7 have been characterized in
mice.12 These mutants show hypopigmentation, but no
gross behavioral abnormalities, in paradigms probing anx-
iety and stress-related behavior. Assessing the impact of
Dock7 disruption on cortical function in these mice would
require extended testing of specific cognitive paradigms.
The function of cortical networks depends on an exqui-
site balance between synaptic excitatory and inhibitory
activities, respectively mediated by glutamatergic pyrami-
dal cells and GABAergic interneurons.13 Indeed, alterations
of GABAergic cell function, either during development or
in the mature brain, can cause increased excitability and
epilepsy. The intractable seizures observed in all three
affected individuals described here could thus result from
the abnormal development of the GABAergic network
associated with the loss of DOCK7 function. Another
prominent feature observed in these individuals is the
presence of cortical blindness, which is typically caused
by altered sensory processing within cortical areas in the
occipital lobes. The early onset of the visual impairment
in our affected individuals and its stability or improvement
later in life suggest that it resulted from a developmental896 The American Journal of Human Genetics 94, 891–897, June 5, 2process. Interestingly, in at least two of the individuals,
brain MRI showed abnormal signals (T2 hyperintensities)
and atrophy in the occipital cortex, including in regions
lining the calcarine sulcus, where the primary visual cortex
is localized. These signal abnormalities might represent
altered axonal or myelin integrity resulting in visual
impairment. Although these changes are typically associ-
ated with sequellae of vascular or inflammatory insults,
the mechanism underlying their development in the
context of the genetic condition described here is uncer-
tain. The individuals described here also display an abnor-
mally marked pontobulbar sulcus and mild pontine
hypoplasia, which should alert clinicians to the disorder
described here and to a potential involvement of DOCK7.
In summary, we have described a neurodevelopmental
condition that is causally linked to recessive mutations in
DOCK7. This condition is characterized by specific clinical
features, which should make it readily recognizable by
clinicians. Our work also suggests that pathways involved
in microtubule assembly and chandelier cell development
contribute to the pathogenesis of EE.Supplemental Data
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